CBD and Hemp

©Getty Images - David Trood

FDA slams Delta-8 THC sellers over claims

By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

Getty Images / Adie bush

Poll finds many parents don't understand CBD

By Danielle Masterson

Despite the wide availability of CBD in its various forms—oil, topical ointments, tinctures, vaping and edibles— a recent poll shows parents are misinformed on CBD.

Getty Images / MysteryShot

CBD price per mg trending down, report finds

By Danielle Masterson

Despite a whopping 3,561% gap between the most expensive and least expensive products across the CBD industry, the overall category is getting cheaper for consumers.

Getty images /  skynesher

Leafreport finds over half CBD products mislabeled

By Danielle Masterson

The CBD watchdog released a market analysis, revealing that of the 221 products tested, only 40% matched the labeled CBD strength and many contained the wrong type of CBD.

©Getty Images - Nastco

USP commentary sounds safety, quality alarm on delta-8 THC

By Hank Schultz

The United States Pharmacopeia (USP) has published a commentary raising potential safety and quality control concerns about the delta-8 THC products flooding the market. The document also raised issues with other cannabinoids that are being isolated...

Getty Images /  Tinnakorn Jorruang

Leafreport: Half of CBG products tested don't meet label claim

By Danielle Masterson

With CBG more difficult to source than CBD, Leafreport sought to find out whether this meant a lot of CBG products were on the market that didn't meet label claims listing the amount of the cannabinoid shoppers should expect to find inside.

 HempRise recently welcomed Congressman Trey Hollingsworth (second from right) and other regional hemp advocates for a tour of its new 100,000-square-foot facility. Image credit: HempRise

HempRise gears up to open $80m hemp processing facility in Indiana

By Elaine Watson

When Layn Corp subsidiary HempRise first announced plans to invest a cool $80m into a state-of-the-art hemp processing facility in Jeffersonville Indiana a couple of years ago, the expectation was that by the time it opened, we’d have clarity on the regulatory...

©Getty Images - Nastco

CDC, FDA issue warnings about delta-8 THC safety

By Hank Schultz

US federal regulatory agencies have issued warnings on the availability of delta-8 THC, saying reports of almost 150 recent emergency room visits have mentioned the substance.

©Getty Images - Nastco

California Gov. Newsom expected to sign hemp bill

By Hank Schultz

The California Legislature has passed a bipartisan bill to establish rules for the production and marketing of CBD/hemp products. Proponents expect Gov. Gavin Newsom to sign the bill into law before the Oct. 10 deadline.

©Getty Images - jetacomputer

FDA rejects two NDI filings on full spectrum hemp extracts

By Hank Schultz

The US Food and Drug Administration has rejected two New Dietary Ingredient Notifications for CBD ingredients. Industry stakeholders said the fact of the rejections and some of wording used in the letters makes it clear that new legislation is likely...

Getty Images /  IRA_EVVA

The blurred lines of the legality of Delta-8

By Danielle Masterson

Months ago, many may not have even been aware of the existence of this cannabis compound. Today, Delta-8 is the fastest-growing category of hemp products, with US sales of products listing Delta-8 jumping 144% from a year earlier, according to cannabis...

© Robert Daly / Getty Images

The challenges with CBD for sports nutrition

By Shane Starling

The CBD sports nutrition sector had its game significantly boosted in 2018 when the World Anti-Doping Agency (WADA) removed the hemp-derived cannabinoid from its list of banned performance-enhancing substances – the market duly took off.

©Getty Images - Nastco

Bipartisan Senate CBD bill introduced

By Hank Schultz

A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.

Follow us

Products

View more

Webinars